BioWorld

Dec. 4, 1996

View Archived Issues

CATS, DOGS CHECK OUT NEW CANCER GENE THERAPY

Read More

ISIS GETS FIRST $10M MILESTONE IN BOEHRINGER INGELHEIM ANTISENSE PACT

Read More

ALTEON AMENDS PHASE III TRIAL PROTOCOL FOR PIMAGEDINE DUE TO ADVERSE

Read More

ATHENA NEUROSCIENCES' ZANAFLEX GETS FDA MARKETING APPROVAL

Read More

CHEMGENICS SIGNS POTENTIAL $70M DEAL WITH AMERICAN HOME PRODUCTS

Read More

SMITHKLINE BEECHAM, IDEC BEGIN PHASE III TRIALS OF RHEUMATOID

Read More